PTHL (Pheton Holdings) Short-Term Debt to Capital

Corporate company logo of Pheton Holdings Limited (PTHL)

Pheton Holdings Ltd (PTHL) is currently reorganizing component logistics and switching Asian contractors to reduce production costs. Meanwhile, tensions between Washington and Beijing are hindering the global rollout of medications and data exchange. This price chart, where the indicator stands at 0.03, confirms the business's critical dependence on external production sites and the strict schedules of third-party suppliers.

Ratio of Short-Term Indebtedness to Capital: ftzy.com.cn (PTHL) for 09/06/2024 - 01/16/2026
Brand item of ftzy.com.cn

Investors utilize this ratio for liquidity stress testing by comparing liabilities maturing within one year against total equity. For Pheton Holdings Ltd (PTHL), which is scaling its business through oncology equipment maintenance services, the chart of short-term liabilities to equity reflects the balance between operating leverage and the risk of funding shortages, determining the sustainability of the long-term revenue model.

Competitors of Pheton Holdings Ltd (PTHL)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|EXOZ (Invizyne Technologies) - Current Liabilities to Equity|Oramed Pharma - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital ENTX (Entera Bio Ltd.)|HYFT: Short-Term Debt to Capital|Current Liabilities to Capital abvcpharma.com (ABVC)|Short-Term Debt to Equity Ratio CPIX|QNTM (Quantum BioPharma Ltd.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Equity FibroGen Corp (FGEN)|TELO - Current Liabilities to Capital|Short-Term Debt to Equity Rani Therapeutics Holdings, Inc. RANI|SNYR: Short-Term Debt to Capital Ratio|RLYB: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital LEXX (Lexaria Bioscience)|PULM: Short-Term Debt to Capital|Aptorum Group - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Lyra Therapeutics, Inc.|Current Liabilities to Capital impactbiomedinc.com IBO|Short-Term Debt to Equity TNF Pharmaceuticals (TNFA)|Short-Term Debt to Equity YCBD (cbdmd.com)|Short-Term Debt to Capital PRFX (PainReform Limited)|CYTO: Short-Term Debt to Capital Ratio|Lipella Pharmaceuticals - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient optinose.com OPTN|Pieris Pharmaceuticals, Inc. (PIRS) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio PROC|PTPI (Petros) - Short-Term Debt to Capital|QLI - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Acelyrin, Inc. (SLRN)|Short-Term Debt to Capital Coefficient tffpharma.com